Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks].
Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX. Kali S, et al. Among authors: bourner j. Virologie (Montrouge). 2023 Feb 1;27(1):23-26. doi: 10.1684/vir.2023.0985. Virologie (Montrouge). 2023. PMID: 36891777 French. No abstract available.
MOSAIC: a European cohort study of human Mpox - the challenges of clinical research in outbreaks.
Kali S, Bourner J, Calmy A, Laouénan C, Merson L, Cervantes-Gonzalez M, Rojek A, Pesonel E, Guiraud L, Tardivon C, Descamps D, Diallo A, Gibowski S, Rosenthal E, Petrov-Sanchez V, Letrou S, Hoffmann I, Le Mestre S, Mentré F, Yazdanpanah Y, Olliaro P, Lescure FX. Kali S, et al. Among authors: bourner j. Virologie (Montrouge). 2023 Feb 1;27(1):12-15. doi: 10.1684/vir.2023.986. Virologie (Montrouge). 2023. PMID: 36896770 No abstract available.
The impact of COVID-19 on clinical research for Neglected Tropical Diseases (NTDs): A case study of bubonic plague.
Rasoanaivo TF, Bourner J, Randriamparany RN, Gamana TM, Andrianaivoarimanana V, Raherivelo MH, Randriamampionona H, Rajerison M, Raberahona M, Salam AP, Edwards T, Olliaro PL, Randremanana RV. Rasoanaivo TF, et al. Among authors: bourner j. PLoS Negl Trop Dis. 2021 Dec 20;15(12):e0010064. doi: 10.1371/journal.pntd.0010064. eCollection 2021 Dec. PLoS Negl Trop Dis. 2021. PMID: 34928955 Free PMC article.
Laboratory Diagnosis of Mpox, Central African Republic, 2016-2022.
Garba-Ouangole S, Bourner J, Mbrenga F, Gonofio E, Selekon B, Manirakiza A, Kalthan E, Malaka C, Boum Y 2nd, Olliaro P, Nakouné E. Garba-Ouangole S, et al. Among authors: bourner j. Emerg Infect Dis. 2023 Sep;29(9):1846-1849. doi: 10.3201/eid2909.230514. Epub 2023 Jul 12. Emerg Infect Dis. 2023. PMID: 37437563 Free PMC article.
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
Olayinka AT, Bourner J, Akpede GO, Okoeguale J, Abejegah C, Ajayi NA, Akude C, Ayodeji O, Bausch DG, de Clerck H, Dan-Nwafor C, Dunning J, Erameh C, Eze JN, Formenty P, Gillesen A, Jalloh S, Jaspard M, Jegede T, Maikere J, Malvy D, Ogbaini-Emovon E, Ojo OE, Okogbenin S, O'Neill K, Orji ML, Owhin SO, Ramharter M, Samuels RJ, Shehu N, Merson L, Salam AP, Kayem ND, Horby P, Ihekweazu C, Olliaro P. Olayinka AT, et al. Among authors: bourner j. PLoS Negl Trop Dis. 2022 Jan 6;16(1):e0010089. doi: 10.1371/journal.pntd.0010089. eCollection 2022 Jan. PLoS Negl Trop Dis. 2022. PMID: 34990453 Free PMC article.
Tecovirimat for Monkeypox in Central African Republic under Expanded Access.
Mbrenga F, Nakouné E, Malaka C, Bourner J, Dunning J, Vernet G, Horby P, Olliaro P. Mbrenga F, et al. Among authors: bourner j. N Engl J Med. 2022 Dec 15;387(24):2294-2295. doi: 10.1056/NEJMc2210015. Epub 2022 Nov 30. N Engl J Med. 2022. PMID: 36449745 Free PMC article. No abstract available.
Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).
Pesonel E, Laouénan C, Guiraud L, Bourner J, Hoffmann I, Molino D, Tardivon C, Bachelet D, Mentré F, Amstutz A, Merson L, Rojek A, Cervantes Gonzalez M, Antinori A, Castagna A, Nozza S, Pourcher V, Libois A, Dunning J, Tacconelli E, Hites M, De La Calle Prieto F, Horby P, Yazdanpanah Y, Calmy A, Lescure FX, Olliaro P; MOSAIC Study Group. Pesonel E, et al. Among authors: bourner j. Clin Infect Dis. 2025 Jan 3:ciae657. doi: 10.1093/cid/ciae657. Online ahead of print. Clin Infect Dis. 2025. PMID: 39749987
An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial-an update to the published protocol.
Randremanana RV, Raberahona M, de Dieu Randria MJ, Bourner J, Zadonirina G, Razananaivo H, Mayouya-Gamana T, Mangahasimbola R, Pesonel E, Gillesen A, Rajerison M, Andrianaivoarimanana V, Edwards T, Horby P, Olliaro P. Randremanana RV, et al. Among authors: bourner j. Trials. 2024 Jul 5;25(1):457. doi: 10.1186/s13063-024-08302-7. Trials. 2024. PMID: 38970065 Free PMC article.
20 results